Sunday, December 16, 2018 9:23:44 AM
STONY BROOK, NY. August 18, 2015. Applied DNA Sciences, Inc. (NASDAQ
: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that it has entered into a two-year contract with another U.S. government agency. Terms of the contract, including the scope of services, are confidential.
Dr. James A. Hayward, President and CEO of APDN stated, "This new contract is a testament to our success in building awareness within U.S. government agencies of the power of SigNature® DNA to provide supply-chain assurance and security. Our platform is flexible, unique and functions with the security and scale that government agencies need. By validating the effectiveness of SigNature DNA, we hope to create a significant opportunity from this contract for our DNA marking technology to become the regulatory standard used to enforce applicable federal law."
In addition to the contract announced today, Applied DNA is working with four agencies within the U.S. government sector where its DNA marks are used to establish forensic traceability to prevent the intrusion of counterfeit parts into government supply chains, including the Defense Logistics Agency (DLA). Current contracts with the Missile Defense Agency (MDA), and the Office of the Secretary of Defense (OSD) require the company to expand production scope and scale of production to accommodate as many as 100 component manufacturers, and to develop methodologies and commercial relationships capable of DNA-marking diversified parts ranging from O-rings to fasteners and electrical wire with historical DLA procurement volume of nearly 150,000,000 items.
Recent BNBX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/27/2026 12:15:32 PM
- BNB Plus Corp. (BNBX) Secures Initial Commitments for $4.1M in Strategic Financing • Business Wire • 05/26/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:21:22 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 12:30:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 08:10:24 PM
- BNB Plus Corp. Completes Historic $1.2 Million LineaDNA™ Order • Business Wire • 04/23/2026 11:00:00 AM
- BNB Plus Corp. Announces Review of Strategic Alternatives to Maximize Shareholder Value • Business Wire • 04/20/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:09:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:08:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:07:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:06:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:06:14 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/24/2026 08:15:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:06:00 PM
- BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea™ IVT Platform • Business Wire • 03/18/2026 12:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/12/2026 09:24:23 PM
- BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA™ from Genetic Medicine Developers • Business Wire • 02/24/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 09:16:58 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/13/2026 07:49:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2026 09:32:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 09:11:07 PM
- BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board Director • Business Wire • 02/05/2026 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/30/2026 09:06:16 PM
